Bat Saliva May Help Stroke Disability
Posted on: Thursday, 13 September 2007, 15:00 CDT
U.S. researchers are challenging the standard three-hour stroke treatment window by using bat saliva to help stroke victims avoid debilitating side effects.
Stroke is the No. 1 disabling condition for adults in the United States. But Cleveland Clinic scientists say that high ranking of stroke disability is due, in part, to the limited 3-hour window physicians have to care for individuals after stroke onset.
In the new research, Dr. Anthony Furlan, associate director of the Cleveland Clinic's Cerebrovascular Center, is studying a naturally occurring, clot-dissolving agent found in vampire bats' saliva.
Known as Desmoteplase, the substance is being tested as a potential therapeutic substance to dissolve blood clots that cause stroke.
Currently, no other specific stroke treatment exists for individuals who are not cared for within the 3-hour treatment window.
Furlan said the blood clot-dissolving agent has shown positive results in two of three trials. The Cleveland Clinic researchers are now determining which stroke patients are most likely to benefit from Desmoteplase.
Source: United Press International
Related Articles
- New Stroke Treatment is Developed
- Doctors Call for Better Stroke Treatment
- AIDS Healthcare Foundation and the Royal Government of Cambodia to Partner in New Free AIDS Treatment Clinic in Koh Thum
- AIDS Healthcare Foundation Presents Amigos Y Amantes, an Art Exhibition and Auction to Benefit Its Free AIDS Treatment Clinics in Mexico
- CoAxia(TM) Announces FDA Approval of Clinical Trial for Its Novel Stroke Treatment in Patients Up to 24 Hours After Onset
- AHF: New AIDS Treatment Clinic to Open in Guatemala in Partnership With the Global Fund and Local Partners
- AHF Partners in Two New Free AIDS Treatment Clinics in Rwanda
- Stroke Center Hospitals Are Key to Insure Best Stroke Treatment
- Stroke treatment a step closer after trial
- Statin Treatment within First 24 Hours after Heart Attack Cut Mortality by Half
User Comments (0)

RSS Feeds